Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® 5 Pods in the U.S.

If your email program has trouble displaying this email, view as a webpage.

Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® 5 Pods in the U.S.

• Medical Device Correction impacts only specifc lots of Omnipod® 5 Pods
• Customers can visit omnipod.com/check-podsExternal Link Disclaimer to check lot numbers and request replacement Pods at no cost
• All other Omnipod® 5 Pods and Omnipod® products remain safe to use

ACTON, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (“Insulet” or the “Company”) today initiated a voluntary Medical Device Correction for specific lots of Omnipod® 5 Pods after identifying a manufacturing issue through its ongoing product monitoring. This action applies to specific identified lots distributed in the United States, and all other Omnipod® 5 Pods and Omnipod® products remain safe to use.

Insulet identifed that certain Pods from specific lots may have a small tear in the internal tubing that delivers insulin. If this occurs, insulin may leak inside the Pod instead of being fully infused into the body as intended.

View Full Recall